Independent and joint effects of antibodies to human heat-shock protein 60 and Chlamydia pneumoniae infection in the development of coronary atherosclerosis.
about
Tolerization against atherosclerosis using heat shock protein 60Chlamydia pneumoniae exacerbates aortic inflammatory foci caused by murine cytomegalovirus infection in normocholesterolemic miceRole of infectious and immune factors in coronary and cerebrovascular arteriosclerosisEffects of repeated Chlamydia pneumoniae inoculations on aortic lipid accumulation and inflammatory response in C57BL/6J miceInflammation in acute coronary syndromes.Serum antibody titers against heat shock protein 27 are associated with the severity of coronary artery disease.Heat shock protein 60 and immune inflammatory responses in atherosclerosisIncreased titres of anti-human heat shock protein 60 predict an adverse one year prognosis in patients with acute cardiac chest painProtective effect of human heat shock protein 60 suggested by its association with decreased seropositivity to pathogensMolecular chaperones and heat shock proteins in atherosclerosis.Heat shock protein 60 stimulates the migration of vascular smooth muscle cells via Toll-like receptor 4 and ERK MAPK activationAutoantibodies to heat shock protein 60 promote thrombus formation in a murine model of arterial thrombosisRole of antiheat shock protein 60 autoantibodies in atherosclerosis.Association of autoantibodies to heat-shock protein 60 with arterial vascular events in patients with antiphospholipid antibodies.Reduction in the level of antibodies against heat shock proteins 60 during different hormonal protocols in postmenopausal women.Genetic variation in heat shock protein 60 gene and coronary heart disease in China: tagging-SNP haplotype analysis in a case-control study.Circulating anti-heat-shock-protein antibodies in normal pregnancy and preeclampsia.Diagnosis and Therapy of Atrial Fibrillation: The Past, The Present and The Future.Immune-mediated mechanisms of endothelial damage in atherosclerosis.Auto-antibodies as emergent prognostic markers and possible mediators of ischemic cardiovascular diseases.A soluble factor(s) released by MRC-5 cells early and late after human cytomegalovirus infection induces maturation of monocyte-derived dendritic cells.High prevalence of Chlamydia pneumoniae antibodies and increased high-sensitive C-reactive protein in patients with vascular dementia.Immunization with P277 induces vascular leak syndrome in C57BL/6 mice via endothelial damage.Proteomics of MUC1-containing lipid rafts from plasma membranes and exosomes of human breast carcinoma cells MCF-7.CD4+CD28null T Cells are related to previous cytomegalovirus infection but not to accelerated atherosclerosis in ANCA-associated vasculitis.Comparison of epitope specificity of anti-heat shock protein 60/65 IgG type antibodies in the sera of healthy subjects, patients with coronary heart disease and inflammatory bowel disease.Evaluation of antibodies against human HSP60 in patients with MPO-ANCA associated glomerulonephritis: a cohort studyHeat shock proteins in cardiovascular disease and the prognostic value of heat shock protein related measurements.HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway.Association between indices of body mass and antibody titres to heat-shock protein-60, -65 and -70 in healthy Caucasians.Helicobacter pylori infection in connective tissue disorders is associated with high levels of antibodies to mycobacterial hsp65 but not to human hsp60.Chlamydia pneumoniae Infection Exacerbates Atherosclerosis in ApoB100only/LDLR-/- Mouse Strain.
P2860
Q28081051-162E7C0F-C9F0-46F8-B64F-07181D5D5806Q28362988-CE87B16A-A686-4309-ABB6-711BFF9D83A8Q33942966-AE4DA9A3-2104-4AC6-BFA1-556079E979DFQ34033240-6B8BA24D-E981-41B1-91E6-6661192875E0Q34532851-73E95BEE-1486-464C-83AF-D3ED8190AC6FQ34797210-299B9576-6340-4EE6-8642-6B040FE931F3Q35540113-E25C9FAB-1EF9-40C6-BFA1-A98840D400C3Q35584657-0B3AFEC8-CB41-47C5-9D06-BDE07E1E57F9Q35636090-548610A9-74A5-49B5-AD0C-FC1A99EE53F1Q35964911-BAAAC285-91C3-4C79-9D7A-5CFFCAF4428EQ36174708-B0BDF311-A4F2-45A6-93B8-E0315CD47128Q36194556-6247FC47-2E24-4684-9FB9-621547206478Q36283491-94A7E04D-35CC-4BAA-9388-3EC3B094D766Q36300623-C3F4A9E2-6302-4075-9E85-E0263E1AEE47Q36523704-E940D978-41B5-49F3-959E-A52CAFBA7CFAQ37170865-42B159F8-E916-41E0-8488-51C69CC7D892Q37308870-0F601999-0D46-4D61-B121-477EA516A0A7Q37468899-D4FA2621-F1BD-4814-8979-4258A7F7692AQ37622950-6F144982-3D89-4825-8ECA-B1F300B695D3Q37824302-0A1E0DA8-C7EC-4D60-A1C1-8E9C7B3F0174Q37862068-FE539B1B-E82A-48B3-926B-2643502CAF8FQ37865107-903282C6-9605-414A-B5D5-69D79B799BD2Q39709295-C8F025CC-ED38-4A22-A183-34644137A76DQ39856870-751E917E-6C36-456E-88A6-1F095096C3DAQ40373160-A58E590B-CB7E-4D97-905C-191F436ECC38Q40890755-F13599F3-DA98-4B36-BAF6-F99DB661C3EDQ42421542-E97A6325-4E4A-48FB-AE29-36DF9FC825A8Q43012408-8E98B8F9-0B32-4BA9-AF32-804A0112FE55Q46600841-D8B6A1CE-0415-45C7-A519-4328736F4864Q51805026-2F82A6BB-99D1-416B-BB0C-5A46B9F86E41Q53920772-489746F2-6F11-4F01-8CDD-92108ADCFD0AQ55038629-D5FDD0C3-063E-41FC-8D84-F944D5F40029
P2860
Independent and joint effects of antibodies to human heat-shock protein 60 and Chlamydia pneumoniae infection in the development of coronary atherosclerosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2001
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Independent and joint effects ...... t of coronary atherosclerosis.
@en
Independent and joint effects ...... t of coronary atherosclerosis.
@nl
type
label
Independent and joint effects ...... t of coronary atherosclerosis.
@en
Independent and joint effects ...... t of coronary atherosclerosis.
@nl
prefLabel
Independent and joint effects ...... t of coronary atherosclerosis.
@en
Independent and joint effects ...... t of coronary atherosclerosis.
@nl
P2093
P50
P1433
P1476
Independent and joint effects ...... nt of coronary atherosclerosis
@en
P2093
Berencsi K
P304
P356
10.1161/01.CIR.103.11.1503
P407
P577
2001-03-01T00:00:00Z